SOUTH SAN FRANCISCO, CA--(Marketwired - Mar 7, 2016) - Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced today that the U.S. Food and Drug Administration has provided written feedback on the ...

COLUMBUS, Ohio, May 5 Roxane Laboratories, Inc. announcedtoday the approval of its Abbreviated New Drug Application (ANDA) forRopinirole Hydrochloride Tablets, 0.25mg ...

SOUTH SAN FRANCISCO, Calif., Oct. 11, 2017 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases ...

Learn everything you need to know about Ropinirole-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

May 12, 2005 — The U.S. Food and Drug Administration (FDA) has approved ropinirole HCl tablets for the treatment of moderate to severe primary restless legs syndrome (RLS) in adults, budesonide ...

Philadelphia, PA (August 1, 2004) – New data published in the August issue of SLEEP shows that patients with primary Restless Legs Syndrome (RLS) and with periodic leg movements during sleep (PLMS), ...

Research Triangle Park, NC (December 15, 2004) – Study results published today in the journal Movement Disorders show that Requipâ(ropinirole HCl) Tablets effectively treats the symptoms of primary ...

Drug maker Dr Reddy's Laboratories (DRL) gained over 1% to touch an intraday high of 1,634 on Thursday after company launched Ropinirole Hydrochloride XR tablets in the US. Ropinirole Hydrochloride is ...

Co announces that the U.S. FDA has accepted for filing the application by its partner, GlaxoSmithKline (GSK), for REQUIP XL 24-Hour Extended-Release Tablets, the proposed brand name for a once-daily ...

Some patients have been sickened and at least one may have died when they were inadvertantly given the antipsychotic drug risperidone (Risperdal) instead of the Parkinson’s drug Requip (ropinirole) or ...